World Health Organization scientist Soumya Swaminathan recently said that the Delta variant of Covid-19, first identified in India, is becoming the predominantly global variant of the disease.
"The Delta variant is on track to become the dominant variant globally due to its increased transmissibility," Soumya Swaminathan (via the Guardian) told a news conference.
Swaminathan added that the results from the initial trial of the CureVac vaccine were disappointing. The German firm vaccine proved to be only 47% effective.
In early June, the WHO announced that the Delta variant is more troubling. A study in the US, showed that this variant is associated with almost double the risk of hospitalization, compared to another variant , Alpha.
In a report three days ago, it was said that for now, about 10% of cases with Covid-19 in the US can be attributed to the Delta variant. But that percentage is doubling every two weeks, according to Scott Gottlieb, a former U.S. Food and Drug Administration commissioner.
Meanwhile, studies suggest that those who are fully vaccinated have protection against the Delta variant. Early findings suggest that two doses of the Pfizer / BioNTech vaccine protect against the Delta variant. The Oxford / AstraZeneca vaccine offered 60% protection against Delta variant infection.
- A new variant of the coronavirus is on the rise: Why experts in the US are concerned
- Expert says Covid will never leave, but this is not necessarily bad news
- Covid risk in autumn is high, despite drops in infections, says WHO
- WHO: 'Covid disappearance is not a reasonable goal'
- Only one type of Delta variant is troubling, says the WHO
